Taken together, these evidences validate PKCθ as a particularly attractive target to selectively manipulate Teff cell functions that are relevant to pathogenesis of different diseases, including, as our results suggested, muscular dystrophy. This evidence concerns the gene PRRT2 and muscular dystrophy.